Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that certain shareholders have agreed to a voluntary resale restriction period covering 17,840,000 common shares extending the period of time before the shares become free trading to July 15, 2020. According to the update, these shares were previously only subject to a statutory hold period. In addition, Champignon Brands also announced its engagement of Gold Standard Media, LLC (“GSM”) to provide marketing and consulting services to raise public awareness of the company, with a specific emphasis on its North American clinical expansion. GSM is a Georgetown, TX-based limited liability company existing under the laws of the state of Texas.

To view the full press release, visit http://cnw.fm/c8Cii

About Champignon Brands Inc.

Champignon Brands is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

The coronavirus pandemic has shown just how essential the cannabis industry is, with numerous territories allowing medical and recreational pot shops to continue operating during the lockdown and granting them certain permissions to keep transactions between staff and employees smooth and safe. The Jamaican government, for instance, recently announced that it will be allowing medical marijuana patients to make cannabis purchases online for pickup at ‘herb houses’ to maintain social distancing and help combat the spread of the coronavirus.

The interim rule change was made by the country’s Cannabis Licensing Authority [CLA] in coordination with the Ministry of Industry, Commerce, Agriculture and Fisheries and announced last week. They are designed to keep pot shops, or ‘herb houses’ open for businesses while minimizing the public’s exposure to the coronavirus. Under the new rules, patients who have already registered with a cannabis dispensary will be able to order products from the dispensary online and pick them up.

According to regulators, the move is “meant to minimize the length of time spent in such licensed facilities thereby limiting the exposure of staff and patients alike.” Faith Graham, the Cannabis Licensing Authority director of enforcement and monitoring said in a press conference that the agency is “cognizant of the far-reaching effects of the pandemic and remains vigilant and proactive in taking steps to secure the industry.”

Marijuana dispensaries that want to opt in to online ordering will have to submit documents including government issued photo identification and proof of registration in the medical cannabis program to the CLA. They are also required to “submit reports and inventory to the CLA in accordance with the required standards and within stipulated time lines.” In light of the coronavirus pandemic, the CLA has also crafted new but temporary rules regarding cannabis imports and exports.

The change in policy is a reflection of the global legal cannabis landscape. Most territories that deemed cannabis an essential service also allowed online ordering, curbside pickups and in some cases, home deliveries to reduce congestion in the shops and keep both staff, customers and medical marijuana patients safe. A large percentage of medical marijuana patients are advanced in age and have compromised immunities, putting them in greater danger of succumbing to COVID-19.

The new rules will allow these patients to stay safe as they purchase the medicine they need and it will keep herb houses afloat at a time of great financial upheaval.

Experts say such a proactive approach in dealing with the challenges faced by the cannabis industry at this time gives sector players like Round Meadow Holdings Corp. and Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) hope that even the other obstacles in the way of the industry will also be eventually addressed.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, on Monday announced the appointment of Dr. Bill Wilkerson, LL.D. (Hon), an 8-time award-winning pioneer in workplace mental health, to its board of directors. In addition, the company reported the resignation of Mr. Joe Perino from its board of directors. “We are thrilled to welcome Dr. Wilkerson to our board of directors. I look forward to working with him on a personal level as his decades of thought leadership in mental health and extensive global network will be vital to guiding our strategic initiatives and driving operational growth. As we forge a path forward, Dr. Wilkerson’s counsel and expertise will strengthen our mission-critical solutions to better serve our patients along with our employees and shareholders. I am a strong believer that the best processes have a people-centric vision front of mind. Dr. Wilkerson’s years of steadfast diligence and empathy in this space are a valued contribution to our efforts overall,” Champignon Brands CEO Dr. Roger McIntyre stated in the news release.

To view the full press release, visit http://cnw.fm/ti26K

About Champignon Brands Inc.

Champignon Brands is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the Company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

On May 17, the mayor of Washington D.C. released a budget plan for the 2021 fiscal year, and it may have positive implications for the city’s medical marijuana program. Based on language included in the plan, it looks like the local government is preparing to implement regulations for medical marijuana sales as soon as Congress Okays it. Although low level possession and home cultivation has been legal for adults over 21 since a ballot measure was passed in 2014, the local government has been unable to add a legal sales component due to Congressional interference.

In the budget plan for the 2021 fiscal year, Mayor Muriel Bowser proposes to shift regulators’ and licensing responsibilities for Washington City’s current medical marijuana program from the Department of Health to the Alcoholic Beverage Regulation Administration [ABRA]. In addition, the budget also calls for the ‘establishment of a non-lapsing Medical Cannabis Administration to collect funds received from medical cannabis licensing, permitting and regulating fees. According to a fiscal impact statement, the mayor’s plan would transfer $360,000 in local funds, $600,000 in special purpose revenue and six full time employees from the health department to the ABRA.

Although the move isn’t enough to launch legal cannabis sales in the city, it appears to set the stage for a tax and regulation system. If marijuana legalization legislation is passed when the Alcoholic Beverage Regulation Administration is already regulating cannabis, it would take a lot less time for recreational cannabis sales regulations to be implemented.

“Under the most difficult of circumstances, we crafted a balanced budget that reflects our shared values and priorities, makes significant investment in our residents, and sets the district up for an efficient recovery. I look forward to working with the Council to ensure we invest in health, opportunity, prosperity and equality for the District,’ says Bowser.

However, with Congress’ continued efforts to derail marijuana legalization in Washington City, it may be a while before legal recreational sales are a thing. For several years, Mayor Bowser and a majority of Council members have called for the establishment of a legal recreational marijuana sales program but they have been blocked by a Congress-approved federal spending rider that prevents them from using local tax dollars to pay for it. According to Rep. Eleanor Holmes Norton a vocal critic of the rider, the coronavirus pandemic demonstrates the need to permit retail sales to help offset some of the economic losses.

“At this moment of unparalleled need, D.C. should be able to collect taxes from all available sources, including from recreational marijuana, which is believed to be widely used in the district.”

It remains to be seen what industry players like Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) think about the chances of Washington D.C. breaking free from the Congressional yoke preventing the city from implementing a regulated marijuana industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

As the threat posed by the coronavirus grew bigger, governments around the world issued lockdown orders and instructed all but the most essential businesses to close down. In the days and weeks preceding the stay at home orders, legal marijuana saw a spike in sales as people stocked up for what they thought would be a long period of self-isolation.

However, several provinces in Canada deemed the marijuana industry essential, giving consumers constant access to cannabis during the lockdown. According to cannabis company executives, the COVID-19 boom in cannabis sales is dissipating, and consumers have slowed down their purchasing frenzy.

“There was a kind of pantry-loading in late March when there was a concern that maybe the supply chain would be closing down and whether cannabis as an industry would be deemed essential,” says Michael Singer, Interim Chief Executive of cannabis company Aurora Cannabis Inc.

After the industry was deemed an essential service in several provinces and sales continued even despite the lockdown, he says, things went back down to pre-pandemic levels in April.

“The behaviors were very similar to before that pantry-loading process at the end of March.” During the Edmonton-based company’s third quarter, which includes the first few weeks Canadians spent in self-isolation and ended on March 31, Aurora Cannabis Inc. sold 28,073 pounds of marijuana. This was an increase of 39% from the quarter before.

The spike in sales in March and April wasn’t limited to just Aurora Cannabis Inc. According to provincial cannabis distributor Ontario Cannabis Store (OCS), its online orders tripled in mid-March as the coronavirus outbreak grew more serious. Prior to March 9, the company received 2,500 to 3,500 orders and as people adopted physical distancing and self-isolation measures, orders doubled to 5,000 and in one particular week, to 13,000 orders.

“While it is likely there was some stockpiling, orders have maintained at the 5,000 plus orders per day level; still much higher than before COVID-19. Many products, including edibles and seeds, continue to sell quickly,” says Daffyd Roderick, the OCS’s director of communications.

Due to the increase in orders, cannabis distributors in several provinces including Ontario and Alberta have warned of delays in deliveries. The OCS had to expand its staff and courier service to accommodate the increased demand and Delta 9 Cannabis, a Winnipeg-based cannabis chain, hired 76 new employees. According to co-founder and CEO John Arbuthnot, that’s a roughly 30% increase in his workforce.

Although foot traffic at his stores is still high and cart sizes have increased, there has been a change in consumer attitude, he says.

“Certainly we are seeing that the sentiment from customers in the store has shifted from, ‘Oh my goodness, I need to make a last large purchase,’ to more of just back to business as usual. But it seems, for us, that the uptick in business has been continuing.”

Could this return to normal purchasing behavior signal what may happen in the U.S. cannabis markets in the coming weeks? It would be enlightening to hear what sector players like Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) have to say about these buyer trends.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine, today announced its sponsorship of TheraPsil, a BC-based non-profit coalition of healthcare professionals, policy-makers and community leaders (the “TheraPsil Coalition”) seeking legal access to psilocybin for British Columbians with a palliative diagnosis and psychological distress. According to the update, TheraPsil is focused on: establishing safe, and legal access to psychedelic-assisted therapy for those in medical need, efforts to increase awareness and developing safe and effective protocols for psilocybin-assisted therapy through public education and educational training, as well facilitating research and evaluation in collaboration with Canadian and international partners. “Through our sponsorship, the Champignon team and board are extremely proud to begin collaborating alongside TheraPsil, helping patients in palliative care access new and effective therapies,” Champignon Director Pat McCutcheon said in the news release. “Together we will work to provide countless Canadians facing a palliative cancer diagnosis, along with their families, who also face severe psychological distress, with the treatment options, compassion and hope they deserve.”

To view the full press release, visit http://cnw.fm/Mg01j

About Champignon Brands Inc.

Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the Company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

For the past few years, the medical marijuana industry in Florida has been held back by legislation that puts an immense amount of pressure on sellers. State legislation requires that the medical marijuana industry be vertically integrated. Facilities that sell marijuana on a retail level must also cultivate, process, and transport the product.

There have been plenty of complaints about the state’s vertically integrated system. It caps licenses and essentially requires anyone who wants to opt in to be a one-man army, and critics say most players aren’t skilled enough to handle everything from growing, processing to selling.

In 2016, 71% of Florida residents voted to legalize marijuana on a constitutional amendment. It defined medical marijuana treatment centers as ‘an entity that acquires, cultivates, possesses or transfers, transports, sells, distributes, dispenses or administers marijuana, products containing marijuana, related supplies, or educational materials’ to qualifying patients or their caregivers and is registered by the Department of Health.’

However, a bill signed into law in 2017 by then-Governor Scott says that a ‘licensed medical marijuana treatment center shall cultivate, process, transport and dispense marijuana for medical use,’ thus creating a vertically integrated system. Opponents have said the law doesn’t align with the constitutional amendment, with Florida Governor Ron Desantis likening vertical integration to a cartel.

It prevents small companies from entering the industry by creating a high monetary barrier and it makes specialization of one specific aspect like growing or processing almost impossible.

The issue came to a head when a Tampa-based company was denied a medical marijuana license since it did not have a vertically integrated system of growing, processing and selling marijuana and sued the Department of Health. Florigrown says the vertical integration system is unconstitutional and goes against the constitutional amendment that legalized marijuana and gave licensed companies permission to sell.

According to Florigrown, the amendment was intended to create an open industry where people can specialize in different aspects of the supply chain. By using the word ‘or’ the amendment wasn’t arguing for a vertically integrated system but a ‘horizontal’ structure where firms can perform different aspects of the business.

Joe Jacquot, Governor Ron DeSantis’ general counsel represented the Department of Health. He argues that the 2017 law does not conflict with a “proper, textual interpretation” of the constitutional amendment.

“Nothing in the amendment prescribes a horizontal marker model, nor does the amendment elbow out the legislature’s vertical integration,” he told court justices.

Florigrown’s lawyer Katherine Giddings, on the other hand, argues that the Legislature’ cannot “under the guise of public policy come in and change the plain text of the Constitution.”

“There’s something wrong with a system that keeps competition out, products scarce and prices outrageously high, that is harming Florida’s critically and terminally ill patients from getting medical marijuana at reasonable prices. And it is totally contrary to fair market principles.” This case is before the state Supreme Court and analysts say the entire cannabis industry, including Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), will be watching how the highest court will rule on this dispute that may shake the cannabis program to its core.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine, today announced its appointment of Dr. Roger McIntyre as its Chief Executive Officer. Among several additional roles, Dr. McIntyre is a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto. “We are extremely pleased and fortunate to be able to bring Dr. McIntyre aboard as CEO,” Champignon Director Gareth Birdsall stated in the news release. “Dr. McIntyre’s is the world’s leading authority on depression and associated mood disorders, which is further crystalized by his foresight in founding Canada’s first integrated mood disorder treatment and integrated research center in the CRTCE. Dr. McIntyre’s clear ability to execute and his entrepreneurial nature, along with a demonstrated capacity to lead and delegate in dynamic and growing organizations, represent the skill sets that Champignon needs as it moves towards our North American clinic expansion and maturing novel drug discovery initiatives.”

To view the full press release, visit http://cnw.fm/E5z0a

About Champignon Brands Inc.

Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the Company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1)  access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

When state governments started ordering lockdowns and issuing stay at home orders, the economy took a severe hit. So severe, in fact, that the federal government passed a $2 trillion emergency relief package. Qualified citizens, along with small businesses, would receive cash payments and business loans to help them weather the financial storm.

However, due to ongoing federal prohibition, businesses in the state-legal marijuana sector were barred from accessing these funds. There have been calls from stakeholders, advocates, and lawmakers to rectify the marijuana sector’s omission if the government deploys another relief package.

Massachusetts, it seems, might be ahead of the federal government after lawmakers introduced a bill that would provide relief to marginalized industries like cannabis. On Tuesday, a state legislative committee held a virtual hearing with members and stakeholders to get input on a bill that would establish a state-level Paycheck Protection Program (PPP) for companies unable to access federal relief aid.

Discussed by the Joint Committee on Community Development and Small Businesses and sponsored by the committee’s chair Sen. Diana DiZoglio, the proposal would provide a much-needed injection of cash into a legal industry that has been unfairly left out by the federal government.

According to Beth Waterfall, executive director of cannabis events company ELEVATE Northeast, the creation of a Massachusetts PPP loans program for cannabis businesses would be a momentous step in the right direction to remedy the inequality that legal, tax-paying cannabis-related businesses are facing during the COVID-19 crisis.

Angela Brown, CEO of Massachusetts-based cannabis firm T. Bear Inc. says she had to shut down a day before launching. “We were forced to furlough our entire team, lock the building up, and walk away. And while I wait, I still pay my rent, my lenders, my utilities, and my health insurance for furloughed employees,” she says.

“All small business owners are dealing with these issues. The bills and debt continue to mount as the shutdown prolongs. But the difference is that the cannabis industry doesn’t even have access to disaster relief.” This is the inequality the new bill seeks to remedy. And with medical marijuana deemed essential in Massachusetts, these businesses will definitely need such protections to help them better serve their customers safely.

“Our small businesses are in crisis, as you well know. They not only face a one size fits all attempt at relief by the federal government, which doesn’t take into account the unique commercial makeup and different recovery timelines of individual states,” says bill sponsor DiZoglio.

“It is up to the Commonwealth to close the gaps for all our small businesses and provide equitable relief in the absence of that relief from the federal government.”

It is widely believed that cannabis industry companies like Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) are hoping that all states with marijuana programs come up with ways to support the industry during this pandemic.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.